Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092866 | SCV001249580 | uncertain significance | not provided | 2019-10-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001314405 | SCV001504938 | uncertain significance | Charcot-Marie-Tooth disease type 4 | 2020-07-30 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SH3TC2 protein function. This variant has not been reported in the literature in individuals with SH3TC2-related conditions. This variant is present in population databases (rs551803988, ExAC 0.006%). This sequence change replaces arginine with leucine at codon 369 of the SH3TC2 protein (p.Arg369Leu). The arginine residue is weakly conserved and there is a moderate physicochemical difference between arginine and leucine. |